Obinutuzumab, a potent anti-B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy.
Publication/Presentation Date
7-1-2018
Volume
5
Issue
4
First Page
460
Last Page
460
ISSN
2332-7812
Published In/Presented At
Rakocevic, G., Martinez-Outschoorn, U., & Dalakas, M. C. (2018). Obinutuzumab, a potent anti-B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy. Neurology(R) neuroimmunology & neuroinflammation, 5(4), e460. https://doi.org/10.1212/NXI.0000000000000460
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
29629397
Department(s)
Administration and Leadership
Document Type
Article
COinS